RSS-Feed abonnieren
DOI: 10.1055/s-2007-1000847
Stereoselective Synthesis of New Oxa-Cages via Alkyl Radical Cyclization to Vinylogous Carbonates
Publikationsverlauf
Publikationsdatum:
21. Dezember 2007 (online)
![](https://www.thieme-connect.de/media/synlett/200802/lookinside/thumbnails/10.1055-s-2007-1000847-1.jpg)
Abstract
An efficient strategy is developed for the stereoselective synthesis of unsymmetrical dioxa-cage compounds containing ether linkages employing a 6-exo-trig alkyl radical cyclization to vinylogous carbonates. The radical precursors are obtained from the Diels-Alder adducts via iodoetherification and conversion of the alcohol moiety to vinylogous carbonate. The formation of mono-oxa-cage compounds via an intramolecular 5-exo-trig alkyl radical cyclization to olefin is also described.
Key words
oxa-cages - radical cyclization - vinylogous carbonates - Diels-Alder adducts
- For reviews, see:
-
1a
Eaton PE. Angew. Chem., Int. Ed. Engl. 1992, 31: 1421 -
1b
Griffin GW.Marchand AP. Chem. Rev. 1989, 89: 997 -
1c
Marchand AP. Chem. Rev. 1989, 89: 1011 -
1d
Paquette LA. Chem. Rev. 1989, 89: 1051 -
1e
Klunder AJH.Zwanenburg B. Chem. Rev. 1989, 89: 1035 -
1f
Osawa E.Yonemitsu O. Carbocyclic Cage Compounds VCH; New York: 1992. -
1g
Olah GA. Cage Hydrocarbons Wiley; New York: 1990. - 2
Chao I.Shih JH.Wu HJ. J. Org. Chem. 2000, 65: 7523 - 3
Mdzinarishvili A.Geldenhuys WJ.Abbruscato TJ.Bickel U.Klein J.Van der Schyf C. Neurosci. Lett. 2005, 383: 49 -
4a
Geldenhuys WJ.Malan SF.Murugesan T.Van der Schyf CJ.Bloomquist JR. Bioorg. Med. Chem. 2004, 12: 1799 -
4b
Janin YL. Bioorg. Med. Chem. 2007, 15: 2479 - For some recent examples, see:
-
5a
James B.Suresh E.Nair MS. Synlett 2006, 3479 -
5b
Khan FA.Dwivedi V.Rout B. Tetrahedron Lett. 2007, 48: 207 -
5c
Carreno MC.Luzon CG.Ribagorda M. Chem. Eur. J. 2002, 8: 208 -
5d
Marchand AP.Kumar VS.Hariprakasha HK. J. Org. Chem. 2001, 66: 2072 ; and references therein -
6a
Mehta G.Gagliardini V.Schaefer C.Gleiter R. Org. Lett. 2004, 6: 1617 -
6b
Mehta G.Vidya R. J. Org. Chem. 2001, 66: 6913 -
6c
Mehta G.Vidya R. J. Org. Chem. 2001, 66: 6905 -
6d
Mehta G.Vidya R. J. Org. Chem. 2000, 65: 3497 -
6e
Mehta G.Vidya R.Sharma PK.Jemmis ED. Tetrahedron Lett. 2000, 41: 2999 -
6f
Mehta G.Vidya R.Venkatesan K. Tetrahedron Lett. 1999, 40: 2417 -
6g
Mehta G.Vidya R. Tetrahedron Lett. 1998, 39: 6403 -
6h
Mehta G.Uma R. Chem. Commun. 1998, 1735 -
6i
Mehta G.Vidya R. Tetrahedron Lett. 1997, 38: 4177 -
6j
Mehta G.Vidya R. Tetrahedron Lett. 1997, 38: 4173 -
7a
Wu CY.Lin HC.Wang Z.Wu HJ. J. Org. Chem. 2001, 66: 4610 -
7b
Wu HJ.Chao CS.Lin CC. J. Org. Chem. 1998, 63: 7687 -
7c
Wu HJ.Lin CC. J. Org. Chem. 1995, 60: 7558 -
7d
Wu HJ.Lin CC. J. Org. Chem. 1996, 61: 3820 -
7e
Wu HJ.Wu CY. J. Org. Chem. 1999, 64: 1576 -
7f
Wu HJ.Chern JH. J. Org. Chem. 1997, 62: 3208 -
7g
Wu HJ.Chern JH. Chem. Commun. 1997, 547 -
7h
Lin HC.Wu CY.Wu HJ. J. Chin. Chem. Soc. 1997, 44: 609 ; and references therein -
8a
Prinzbach H.Klaus M. Angew. Chem., Int. Ed. Engl. 1969, 8: 276 -
8b
Marchand AP.Reddy GM.Watson WH.Kashyap R. Tetrahedron 1990, 46: 3409 -
9a
Sasaki T.Eguchi S.Kiriyama T.Hiroaki O. Tetrahedron 1974, 30: 2707 -
9b
Singh P. J. Org. Chem. 1979, 44: 843 -
9c
Coxon JM.Fong ST.McDonald DQ.O’Connell MJ.Steel PJ. Tetrahedron Lett. 1991, 32: 7115 - 10
Suri SC. J. Org. Chem. 1993, 58: 4153 -
11a
Mehta G.Srikrishna A.Reddy AV.Nair MS. Tetrahedron 1981, 37: 4543 -
11b
Mehta G.Nair MS. J. Am. Chem. Soc. 1985, 107: 7519 -
11c
Marchand AP.LaRoe WD.Sharma GVM.Suri SC.Reddy DS. J. Org. Chem. 1986, 51: 1622 -
11d
Fessner WD.Prinzbach H. Tetrahedron 1986, 42: 1797 -
11e
Smith EC.Barborak JC. J. Org. Chem. 1976, 41: 1433 -
12a
Marchand AP.Chou TC. Tetrahedron 1975, 31: 2655 -
12b
Mehta G.Reddy KR. J. Org. Chem. 1987, 52: 460 -
13a
Mehta G.Rao HSP. J. Chem. Soc., Chem. Commun. 1986, 472 -
13b
Mehta G.Rao HSP.Reddy KR. J. Chem. Soc., Chem. Commun. 1987, 78 - For some selected examples, see:
-
14a
Lee E. Pure Appl. Chem. 2005, 77: 2073 -
14b
Kang EJ.Cho EJ.Ji MK.Lee YE.Shin DM.Choi SY.Chung YK.Kim JS.Kim HJ.Lee SG.Lah MS.Lee E. J. Org. Chem. 2005, 70: 6321 -
14c
Song HY.Joo JM.Kang JW.Kim DS.Jung CK.Kwak HS.Park JH.Lee E.Hong CY.Jeong SW.Jeon K.Park JH. J. Org. Chem. 2003, 68: 8080 -
14d
Suzuki K.Matsukura H.Matsuo G.Koshino H.Nakata T. Tetrahedron Lett. 2002, 43: 8653 -
14e
Evans PA.Raina S.Ahsan K. Chem. Commun. 2001, 2504 -
14f
Evans PA.Roseman JD. J. Org. Chem. 1996, 61: 2252 ; and references therein
References and Notes
All the compounds exhibited spectral data consistent with their structures. Melting point, IR, NMR (1H and 13C) and HRMS spectral data for some of the compounds are as follows:
Oxa-cage 7a: IR (neat): 2940, 2871, 1730, 1459, 1382, 1309, 1288, 1245, 1173, 1144, 1110, 1096, 1078, 1070, 1032, 1018, 980, 911, 764 cm-1. 1H NMR (400 MHz, CDCl3): δ = 4.35 (dd, J = 7.9, 4.7 Hz, 1 H), 4.17-4.08 (m, 2 H), 4.04 (d, J = 11.9 Hz, 1 H), 3.99 (d, J = 8.0 Hz, 1 H), 3.91 (ddd, J = 7.5, 5.6, 1.9 Hz, 1 H), 3.70-3.65 (m, 2 H), 2.92 (ABX, J = 15.7, 7.8 Hz, 1 H), 2.66-2.62 (m, 1 H), 2.63 (ABX, J = 15.7, 5.6 Hz, 1 H), 2.38 (dt, J = 10.2, 4.4 Hz, 1 H), 1.92-1.85 (m, 2 H), 1.56 (ddd, J = 7.8, 5.2, 2.5 Hz, 1 H), 1.47 (AB, J = 10.6 Hz, 1 H), 1.32 (AB, J = 10.6 Hz, 1 H), 1.24 (t, J = 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3, DEPT): δ = 172.39 (C), 79.21 (CH), 71.61 (CH), 69.12 (CH2), 65.75 (CH2), 60.44 (CH2), 50.05 (CH), 41.42 (CH), 40.84 (CH), 39.29 (CH), 38.95 (CH2), 37.14 (CH), 33.07 (CH2), 14.32 (CH3). ESI-HRMS: m/z calcd for C14H21O4 [M+ + H]: 253.1440; found: 253.1447.
Oxa-cage 7f: mp 94-96 °C. IR (neat): 2931, 2864, 1728, 1460, 1381, 1271, 1260, 1247, 1173, 1100, 1077, 1060, 1003, 987, 920, 753 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.39-7.30 (m, 4 H), 5.08 (d, J = 8.4 Hz, 1 H), 4.74 (d, J = 2.8 Hz, 1 H), 4.49 (ddd, J = 8.3, 5.8, 0.9 Hz, 1 H), 4.15 (t, J = 6.3 Hz, 1 H), 4.08 (q, J = 7.1 Hz, 2 H), 2.52 (ABX, J = 14.7, 5.8 Hz, 1 H), 2.44 (ABX, J = 14.7, 8.3 Hz 1 H), 2.40-2.33 (m, 3 H), 1.99 (br s, 1 H), 1.90-1.83 (m, 2 H), 1.74-1.66 (m, 3 H), 1.18 (t, J = 7.1 Hz, 3 H). 13C NMR (100 MHz, CDCl3, DEPT): δ = 171.38 (C), 136.94 (C), 136.13 (C), 130.60 (CH), 129.37 (CH), 129.26 (CH), 128.39 (CH), 77.78 (CH), 77.23 (CH), 72.82 (CH), 65.45 (CH), 60.38 (CH2), 41.68 (CH2), 41.51 (CH), 40.93 (CH), 40.58 (CH), 32.42 (CH), 23.95 (CH2), 22.40 (CH), 16.43 (CH2), 14.34 (CH3). ESI-HRMS: m/z calcd for C21H25O4 [M+ + H]: 341.1753; found: 341.1745.
Alcohol 9: mp 115-117 °C. IR (neat): 3411, 3029, 2928, 2863, 1460, 1381, 1274, 1261, 1103, 1060, 1036, 1017, 999, 985, 960, 752, 729 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.40-7.29 (m, 4 H), 5.09 (d, J = 8.4 Hz, 1 H), 4.74 (d, J = 2.6 Hz, 1 H), 4.34 (dd, J = 9.7, 2.7 Hz, 1 H), 4.13 (t, J = 6.2 Hz, 1 H), 3.68 (m, 2 H), 3.12 (t, J = 5.5 Hz, 1 H), 2.43-2.33 (m, 3 H), 2.03 (br s, 1 H), 1.94-1.84 (m, 2 H), 1.76-1.66 (m, 4 H), 1.51 (dq, J = 14.0, 3.8 Hz, 1 H). 13C NMR (100 MHz, CDCl3, DEPT): δ = 136.84 (C), 135.96 (C), 130.52 (CH), 129.49 (CH), 129.21 (CH), 128.50 (CH), 77.63 (CH), 77.25 (CH), 72.75 (CH), 70.19 (CH), 62.20 (CH2), 42.37 (CH), 40.80, (CH), 40.50 (CH), 38.84 (CH2), 32.46 (CH), 24.00 (CH2), 22.83 (CH), 16.38 (CH2). ESI-HRMS: m/z calcd for C19H23O3 [M+ + H]: 299.1647; found: 299.1653.
Oxa-cage 10b: IR (neat): 2937, 2867, 1705, 1639, 1619, 1323, 1189, 1126, 1047, 1006, 981, 911, 882 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.50 (d, J = 12.6 Hz, 1 H), 5.20 (d, J = 12.6 Hz, 1 H), 4.37 (d, J = 18.0 Hz, 2 H), 4.16 (q, J = 7.1 Hz, 2 H), 4.08 (t, J = 8.1 Hz, 1 H), 2.22 (ddd, J = 14.0, 9.0, 4.6 Hz, 1 H), 2.14-2.05 (m, 2 H), 1.96-1.89 (m, 3 H), 1.82 (d, J = 5.1 Hz, 1 H), 1.78-1.63 (m, 2 H), 1.63-1.50 (m, 2 H), 1.38-1.32 (m, 1 H), 1.27 (t, J = 7.1 Hz, 3 H). 13C NMR (100 MHz, CDCl3, DEPT): δ = 168.17 (C), 161.47 (CH), 97.73 (CH), 79.09 (CH), 78.39 (CH), 77.69 (CH), 59.92 (CH2), 41.22 (CH), 40.94 (CH), 38.66 (CH), 36.64 (CH), 35.85 (CH), 25.04 (2C, CH, CH2), 22.09 (CH2), 17.08 (CH2), 14.52 (CH). ESI-HRMS: m/z calcd for C17H22O4Na [M+ + Na]: 313.1416; found: 313.1409.
Oxa-cage 12: mp 165-167 °C. IR (neat): 3102, 2968, 2880, 1725, 1628, 1542, 1461, 1344, 1284, 1273, 1169, 1075, 1012, 905, 730 cm-1. 1H NMR (400 MHz, CDCl3): δ = 9.22 (t, J = 2.1 Hz, 1 H), 9.14 (d, J = 2.1 Hz, 2 H), 5.37 (t, J = 8.5 Hz, 1 H), 4.60 (t, J = 4.2 Hz, 1 H), 4.35 (d, J = 4.2 Hz, 1 H), 2.52 (br s, 1 H), 2.45-2.33 (m, 3 H), 2.19 (q, J = 5.6 Hz, 1 H), 1.83-1.76 (m, 3 H), 1.58 (AB, J = 10.8 Hz, 1 H), 1.31 (AB, J = 10.8 Hz, 1 H). 13C NMR (100 MHz, CDCl3, DEPT): δ = 162.36 (C), 148.80 (C), 134.41 (C), 129.53 (CH), 122.47 (CH), 85.08 (CH), 77.94 (CH), 72.04 (CH), 47.89 (CH), 44.05 (CH), 39.68 (CH), 39.50 (CH), 39.06 (CH), 34.31 (CH), 31.60 (CH2), 24.26 (CH2).
Crystal data for alcohol 9: formula: C19H22O3; unit cell parameters: a = 14.4267(16), b = 6.2541(7), c = 15.9204(17); space group: Pca2(1); CCDC number 652177.
Crystal data for oxa-cage 12: formula: C18H16N2O7; unit cell parameters: a = 29.6325(10), b = 5.9688(2), c = 21.6208(8), β = 121.391(3), space group: C(2)/c; CCDC number 652178. CCDC 652177 and CCDC 652178 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.